Intellectual Property Litigation
Health Care Law
Represented Amgen in biosimilar litigation pursuant to the Biologics Price Competition and Innovation Act (“BPCIA”) regarding competitors’ proposed filgrastim and proposed pegfilgrastim products.
Represented Spansion in International Trade Commission investigation regarding read/write operations in flash memory devices.
Member of trial team representing Samsung in International Trade Commission investigation regarding LTE/4G wireless communications standards.
Member of trial team representing Motorola in litigation regarding F/RAND royalty rates for patents related to 802.11 (Wi-Fi) and H.264 video compression standards.
Represented Motorola in patent litigation regarding features of graphical user interfaces.
Represented Motorola in patent litigation regarding communications session technology relating to persistent communication sessions across multiple user devices.
Represented GN ReSound regarding wireless communication techniques used in hearing aids.
Represented Wyeth/Pfizer in ANDA litigation regarding broad-spectrum antibiotic.
Represented university client in dispute over joint inventorship of patent related to synthetic peptides.
Represented Goldman Sachs in litigation regarding contract dispute resulting from sale of voice recognition software company.
Represented client in connection with FCPA investigation.
Represented pharmaceutical client in connection with government investigation on drug pricing.
A.B. (cum laude), Neuroscience, Bowdoin College,1999
Ph.D., Neuroscience, University of Pennsylvania, 2006
J.D. (cum laude), Fordham University School of Law, 2009
Ropes & Gray LLP
Paul, Weiss, Rifkind, Wharton & Garrison LLP
New York State
Hiro Hagiwara, Steve Baughman, Gene Lee, Conor McDonough, Joint and Divided Infringement: Navigating the Changing Landscape for Multiple Actors and Distributed Systems under U.S. Patent Law, 62 Japan Int. Prop. Assoc. 265 (2015)
Herman, Kenneth B., Scarpati, Jennifer, McDonough, Conor Brew, Faster Regulatory Path for Follow-On Biologics is a Win for Pharma, 6 Pharma Mag. 46 (2010)